Receive a weekly summary and discussion of the top papers of the week by leading researchers in the field.

In Gut ; h5-index 124.0

OBJECTIVE : Tumour pathology contains rich information, including tissue structure and cell morphology, that reflects disease progression and patient survival. However, phenotypic information is subtle and complex, making the discovery of prognostic indicators from pathological images challenging.

DESIGN : An interpretable, weakly supervised deep learning framework incorporating prior knowledge was proposed to analyse hepatocellular carcinoma (HCC) and explore new prognostic phenotypes on pathological whole-slide images (WSIs) from the Zhongshan cohort of 1125 HCC patients (2451 WSIs) and TCGA cohort of 320 HCC patients (320 WSIs). A 'tumour risk score (TRS)' was established to evaluate patient outcomes, and then risk activation mapping (RAM) was applied to visualise the pathological phenotypes of TRS. The multi-omics data of The Cancer Genome Atlas(TCGA) HCC were used to assess the potential pathogenesis underlying TRS.

RESULTS : Survival analysis revealed that TRS was an independent prognosticator in both the Zhongshan cohort (p<0.0001) and TCGA cohort (p=0.0003). The predictive ability of TRS was superior to and independent of clinical staging systems, and TRS could evenly stratify patients into up to five groups with significantly different prognoses. Notably, sinusoidal capillarisation, prominent nucleoli and karyotheca, the nucleus/cytoplasm ratio and infiltrating inflammatory cells were identified as the main underlying features of TRS. The multi-omics data of TCGA HCC hint at the relevance of TRS to tumour immune infiltration and genetic alterations such as the FAT3 and RYR2 mutations.

CONCLUSION : Our deep learning framework is an effective and labour-saving method for decoding pathological images, providing a valuable means for HCC risk stratification and precise patient treatment.

Shi Jie-Yi, Wang Xiaodong, Ding Guang-Yu, Dong Zhou, Han Jing, Guan Zehui, Ma Li-Jie, Zheng Yuxuan, Zhang Lei, Yu Guan-Zhen, Wang Xiao-Ying, Ding Zhen-Bin, Ke Ai-Wu, Yang Haoqing, Wang Liming, Ai Lirong, Cao Ya, Zhou Jian, Fan Jia, Liu Xiyang, Gao Qiang

2020-Sep-30

cancer, liver